VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

NCT07254481 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: VB19055
DRUG: VB19055 placebo

Sponsor

Zhejiang Yangli Pharmaceutical Technology Co., Ltd.